Huasheng Biological: Transfers 80% equity of Wuhan Shengchong for a total price of 5.52 million yuan

Huasheng Biological Announcement: The company and its controlled subsidiary, Wuhan Chongyi Biotechnology Co., Ltd., intend to transfer a total of 80% equity stake in Wuhan Shengchong Technology Co., Ltd. to Wuhan Xingzhishang Technology Partnership (Limited Partnership). The total transfer price for this equity is 5.52 million RMB. After the transaction is completed, the company will hold a 20% equity stake in Wuhan Shengchong, and Wuhan Shengchong will no longer be included in the company’s consolidated financial statements.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)